4
Changes in Ownership
AGIOS PHARMACEUTICALS, INC. Filed Acc 0001439222-23-000123
Chief Executive Officer sold 10,178 shares at $25.48 ($259,335)
- Chief Executive Officer acquired 22,691 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Goff Brian · Chief Executive Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-08-08 | Exercise or conversion : show line 1 in the form 10b5-1 | +22,691 | 36,770 | D | ||
| 2023-08-08 | Sale : show line 2 in the form 10b5-1 | −10,178 | $25.48 | $259,335 | 26,592 | D |
| Open-market sales · 10,178 sh · avg $25.48 · $259,335 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-08-08 | Exercise or conversion : show line 3 in the form 10b5-1 Restricted stock units | −22,691 | 45,382 | D |
Loading xslF345X05/wk-form4_1691698025.xml…